Advertisement
Surgery
Subscribe to Surgery
View Sample

FREE Email Newsletter

New Online Resource Available Specifically for Patients and Their Caregivers Following a Heart Stent Procedure

January 18, 2011 5:42 am | by Bio-Medicine.Org | News | Comments

PARSIPPANY, N.J. and INDIANAPOLIS, Jan. 18, 2011 /- Today, patient support group Mended Hearts, in partnership with Daiichi Sankyo, Inc. and Eli Lilly and Company, launched the Stent Hub – an online resource for acute coronary syndrome (ACS) patients who were treated with...

Carbylan BioSurgery Completes Enrollment in Key Clinical Feasibility Study of Hydros and Hydros TA in Patients With Pain From Knee Osteoarthritis; Core Patent Issued

January 5, 2011 2:35 am | by Bio-Medicine.Org | News | Comments

PALO ALTO, Calif., Jan. 5, 2011 /- Carbylan BioSurgery, Inc. announced today the completion of patient enrollment in their double-blinded, multi-center COR1.0 feasibility trial to evaluate the safety and effectiveness of two products - Hydros and Hydros TA Joint Therapies - in patients...

<i>How I See It: </i>Uncertainty in medical device industry

January 4, 2011 7:38 pm | by Mass High Tech: The Journal of New England Technology | News | Comments

A recent development – the FDA's intention to rescind a 510(k) medical device registration held by ReGen Biologics Inc. – signals the FDA intends to broaden its regulatory powers, leaving companies in the medical device industry and those that invest in development of medical technologies...

Advertisement

Stryker Completes Acquisition of the Neurovascular Division of Boston Scientific

January 3, 2011 7:36 am | by Bio-Medicine.Org | News | Comments

KALAMAZOO, Mich., Jan. 3, 2011 /- Stryker Corporation (NYSE: SYK ) announced today the closing of its previously announced acquisition of the assets of the Neurovascular division of Boston Scientific, the global leader in the approximately $900 million worldwide neurovascular market,...

New Hope for Saving Diabetic Foot from Amputation

December 24, 2010 1:31 pm | by Bio-Medicine.Org | News | Comments

LOS ANGELES, Dec. 24, 2010 /- During ICMS (International Cellular Medicine Society www.cellmedicinesociety.org ) Annual International Congress on Regenerative and Cell Based Medicine Conference held on November 12, 2010 in Las Vegas, Nevada, it was announced that a patient with...

Zimmer Finalizes Acquisition of Chinese Orthopaedic Implant Leader Beijing Montagne Medical Device Co., Ltd.

December 21, 2010 4:33 am | by Bio-Medicine.Org | News | Comments

BEIJING, Dec. 21, 2010 /- Zimmer Holdings, Inc. (NYSE and SIX: ZMH), a global leader in musculoskeletal care, today announced that it has completed the acquisition of Beijing Montagne Medical Device Co., Ltd.  The acquisition further enhances Zimmer's presence in the emerging Chinese...

PharMEDium Announces Propofol, Ready-to-Use, Single Patient, Syringe Service for Operating Room Anesthesia

December 20, 2010 8:34 am | by Bio-Medicine.Org | News | Comments

LAKE FOREST, Ill., Dec. 20, 2010 /- PharMEDium Services LLC, announced the addition of Propofol to its custom operating room anesthesia syringe preparation services.  PharMEDium is the first compounder to offer Propofol in a pre-labeled, single patient, ready-to-use, tamper evident...

Accuray Establishes Medical Affairs Function

December 17, 2010 9:33 am | by Bio-Medicine.Org | News | Comments

SUNNYVALE, Calif., Dec. 17, 2010 /- Accuray Incorporated (Nasdaq: ARAY ), a global leader in the field of radiosurgery, announced today that the company has established a Medical Affairs function to accelerate CyberKnife data collection, utilization and referral patterns and to provide...

Advertisement

Microban International Announces Breakthrough in Antimicrobial Technologies for Medical Devices

December 16, 2010 9:36 am | by Bio-Medicine.Org | News | Comments

HUNTERSVILLE, N.C., Dec. 16, 2010 /- Hospital Acquired Infections (HAI's) are a serious health threat associated with over 100,000 deaths each year.  These secondary infections following surgery are a major contributor to increased healthcare costs; experts estimate they add in...

Solta Medical Ships One Millionth Tip for Thermage and Fraxel Devices

December 16, 2010 6:32 am | by Bio-Medicine.Org | News | Comments

HAYWARD, Calif., Dec. 16, 2010 /- Solta Medical, Inc. (Nasdaq: SLTM ), the pioneer in fractional resurfacing and non-invasive skin tightening and a market leader in aesthetic skin treatments, today announced it has shipped its one millionth tip for the revolutionary Thermage and Fraxel...

Reportlinker Adds European Markets for Video, High-Tech and Integrated OT Equipment 2011

December 14, 2010 9:35 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Dec. 14, 2010  /- Reportlinker.com announces that a new market research report is available in its catalogue: European Markets for Video, High-Tech and Integrated OT Equipment 2011...

Robotic Prostatectomy Expert Dr. David Samadi, MD Discusses Prostate Cancer Staging and Prostate Cancer Recurrence Study

December 14, 2010 9:35 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Dec. 14, 2010 /- A new study in the journal Cancer shows that staging prostate cancer that has not metastasized beyond the prostate gland does predict the outcome, prognosis or risk of cancer recurrence after a radical prostatectomy. "This study confirms what many prostate...

MedShape Solutions, Inc. Secures Investment From IQT to Support U.S. Intelligence Community

December 13, 2010 4:37 am | by Bio-Medicine.Org | News | Comments

ATLANTA, Dec. 13, 2010 /- MedShape Solutions, Inc., the world's leading developer of innovative orthopedic medical devices from shape memory materials, today announced a strategic investment and development agreement from In-Q-Tel (IQT), the strategic investment firm that identifies...

Advertisement

Ascension Orthopedics Implants PyroTITANâ„¢ in France

December 13, 2010 4:37 am | by Bio-Medicine.Org | News | Comments

AUSTIN, Texas, Dec. 13, 2010 /- Ascension Orthopedics, Inc., a market leader in PyroCarbon orthopedic implants, announces the first implantation of the PyroTITAN™ Humeral Resurfacing Implant in France. The PyroTITAN was implanted in a 68-year-old patient suffering from painful...

Injecting New Bone

December 12, 2010 7:34 pm | by Massachusetts Institute of Technology | News | Comments

An artificial bone-like material could speed up recovery from injury.

Phase III Efficacy Data on Bevacizumab Plus Chemotherapy in Early Breast Cancer to be Presented

December 10, 2010 12:34 pm | by AACR | News | Comments

SAN ANTONIO - Results of the GeparQuinto study, randomized Phase III efficacy data on the use of bevacizumab plus chemotherapy to treat women with early breast cancer will be presented at the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium.

Circulating Tumor Cells Predicted Recurrence, Death in Patients with Early-stage Breast Cancer

December 10, 2010 9:32 am | by AACR | News | Comments

SAN ANTONIO - The presence of one to four circulating tumor cells (CTCs) in the blood of early-stage breast cancer patients almost doubled patient's risk of cancer relapse and death, and five or more CTCs increased recurrence by 400 percent and death by 300 percent, according to Phase III...

Combination Therapy Reduced HER2-positive Breast Cancers

December 10, 2010 4:35 am | by AACR | News | Comments

SAN ANTONIO - A combination of lapatinib, trastuzumab and paclitaxel significantly improved tumor response rates than either agent alone among patients with HER2-positive breast cancers, according to data presented at the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium, held...

Pertuzumab and Trastuzumab Combination Improved Efficacy for Women With HER2-positive Breast Cancer

December 10, 2010 4:34 am | by AACR | News | Comments

SAN ANTONIO - The combination of pertuzumab and trastuzumab had superior antitumor activity in women with early HER2-positive breast cancer, according to Phase II study results of the NeoSphere neoadjuvant trial.

Phase III Study Compared Neoadjuvant Therapy with Lapatinib or Trastuzumab for Early Breast Cancer

December 10, 2010 4:34 am | by AACR | News | Comments

SAN ANTONIO - Researchers presented Phase III efficacy data from the GeparQuinto study, a head-to-head comparison of neoadjuvant lapatinib and trastuzumab in combination with chemotherapy for patients with early breast cancer, at the 33rd Annual CTRC-AACR San Antonio Breast Cancer...

Covidien Receives FDA 510(k) Clearance for the iDrive(TM) Powered Stapling System

December 9, 2010 4:35 pm | by Covidien | News | Comments

Company's first powered stapling system provides precision, control, access and visibility during open surgical procedures NORTH HAVEN, Conn., Dec 02, 2010 (BUSINESS WIRE) --Covidien (NYSE: COV), a leading global provider of healthcare products and recognized innovator in surgical...

VirtuoSaph® Plus Endoscopic Vessel Harvesting System from Terumo Continues the Advancement of the Minimally Invasive Technique for Coronary and Peripheral Artery Bypass Graft...

December 9, 2010 5:35 am | by Bio-Medicine.Org | News | Comments

ANN ARBOR, Mich., Dec. 9, 2010 /- Terumo Cardiovascular Systems has announced the introduction of the VirtuoSaph® Plus Endoscopic Vessel Harvesting System following clearance by the U.S. Food and Drug Administration (FDA). (Logo: http://photos.prnewswire.com/prnh/20041217/DEF008LOGO)...

Osseon® Therapeutics Names Gary Coughlen, CPA as New Chief Financial Officer

December 9, 2010 5:34 am | by Bio-Medicine.Org | News | Comments

SANTA ROSA, Calif., Dec. 9, 2010 /- Osseon Therapeutics, Inc. today named Mr. Gary Coughlen, CPA as the company's Chief Financial Officer, effective immediately. Mr. Coughlen was most recently the Chief Financial Officer of PolyRemedy, Inc., a private-equity medical device company focused...

KLS Martin's SonicWeld Rx Changing the Face of Craniomaxillofacial Plate Fixation

December 6, 2010 7:34 am | by Bio-Medicine.Org | News | Comments

TORONTO, Dec. 6, 2010 /- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, US craniomaxillofacial plate and screw market growth will be driven by uptake of new resorbable polymers and novel implantation techniques. KLS Martin's...

Clinical trials at The Christie: Fact sheet

December 2, 2010 3:34 am | by RealWire | News | Comments

Clinical trial treatments aim to discover if a drug is safe, has side effects, and works better than established treatments. They offer important opportunities for patients to access the most innovative treatments for cancer, giving them the best possible chance of survival or extended...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading